BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6131026)

  • 1. [Effects of antianginal agents on myocardial blood flow].
    Rudolph W; Fleck E; Dirschinger J
    Herz; 1982 Dec; 7(6):378-87. PubMed ID: 6131026
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation].
    Busse R; Bassenge E
    Herz; 1982 Dec; 7(6):388-405. PubMed ID: 6131027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of molsidomine on coronary collateral blood flow in acute myocardial ischemia.
    Gross GJ; Gharaibeh M
    Eur J Pharmacol; 1980 Oct; 67(1):111-4. PubMed ID: 6893436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antianginal drugs on ventricular function, myocardial blood flow and peripheral circulation.
    Banka VS; Bodenheimer MM; Helfant RH
    Herz; 1982 Dec; 7(6):366-77. PubMed ID: 6131025
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antianginal and antiadrenergic therapy in acute coronary syndrome].
    Raos V; Bergovec M
    Acta Med Croatica; 2004; 58(2):123-7. PubMed ID: 15208797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of molsidomine during the cold test in stable coronary insufficiency under beta-blocker treatment].
    Zygelman M; Neukirch F; Mérillon JP; Dahan M; Trouillet JL; Juliard JM; Pansard Y; Gourgon R
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1383-9. PubMed ID: 6150693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of the partial beta-adrenergic receptor agonist, oxyfedrine, on regional myocardial blood flow and left ventricular function in patients with coronary artery disease].
    Dirschinger J; Fleck E; Rudolph W
    Herz; 1982 Dec; 7(6):351-7. PubMed ID: 7160821
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of nitrates, beta blockaders and revascularization on myocardial circulation in patients with coronary heart disease (proceedings)].
    Fleck E
    Fortschr Med; 1979 May; 97(17):824. PubMed ID: 35453
    [No Abstract]   [Full Text] [Related]  

  • 10. Molsidomine on cardiovascular leukotriene D4 actions.
    Fiedler VB; Abram TS
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):152-7. PubMed ID: 3839292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological basis of therapy with molsidomine].
    Bassenge E
    Herz; 1982 Oct; 7(5):296-306. PubMed ID: 6897544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the effect of ildamen and nonachlazin on the blood supply and activities of the heart].
    Kaverina NV; Chichkanov GG; Chumburidze VB
    Kardiologiia; 1978 Mar; 18(3):88-93. PubMed ID: 642245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Redistribution of the coronary blood flow, functional improvement of the ischemic myocardium and reduction of the size of an experimental infarction by molsidomine].
    Berdeaux A; Giudicelli JF
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):511-5. PubMed ID: 6364947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Coronarodilating properties of the GABA cyclic derivative TZ-146].
    Galenko-Iaroshevskiĭ PA; Uvarov AV; Sheĭkh-Zade IuR; Cherednik IL; Popov PB; Sirotenko DV
    Biull Eksp Biol Med; 1999 Aug; 127(8):200-3. PubMed ID: 11188744
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of aspirin on the hemodynamic effects of molsidomine in healthy volunteers].
    Weber S; de Lauture D; Puechavy C; Pipeau C; Chazelle F; Degeorges M
    Therapie; 1986; 41(3):153-7. PubMed ID: 3529482
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The activity of human coronary arteries in vitro].
    Godfraind T
    Bull Acad Natl Med; 1985 Feb; 169(2):273-80. PubMed ID: 3899298
    [No Abstract]   [Full Text] [Related]  

  • 18. Comprehensive drug management of angina pectoris.
    Pepine CJ; Feldman RL; Conti CR
    Cardiovasc Clin; 1984; 14(3):139-51. PubMed ID: 6144388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary spasm, steal, and stenosis: implications for management of ischemic heart disease.
    Kern MJ; Miller JT
    Curr Probl Cardiol; 1986 Jan; 11(1):1-67. PubMed ID: 2867859
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-exercise interactions.
    Lowenthal DT; Kendrick ZV
    Annu Rev Pharmacol Toxicol; 1985; 25():275-305. PubMed ID: 2860845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.